Cantel Medical (CMD) Earns Media Impact Rating of -0.04

Headlines about Cantel Medical (NYSE:CMD) have been trending somewhat negative on Monday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Cantel Medical earned a news impact score of -0.04 on Accern’s scale. Accern also gave news headlines about the company an impact score of 45.2547369018011 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Shares of Cantel Medical opened at $95.64 on Monday, MarketBeat.com reports. Cantel Medical has a 1-year low of $72.82 and a 1-year high of $130.92. The company has a current ratio of 2.44, a quick ratio of 1.52 and a debt-to-equity ratio of 0.28. The firm has a market cap of $3.99 billion, a P/E ratio of 45.98 and a beta of 1.09.

Cantel Medical (NYSE:CMD) last announced its earnings results on Thursday, May 31st. The company reported $0.60 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.60. Cantel Medical had a return on equity of 17.07% and a net margin of 10.74%. The firm had revenue of $217.27 million for the quarter, compared to the consensus estimate of $222.00 million. equities research analysts forecast that Cantel Medical will post 2.5 earnings per share for the current fiscal year.

The company also recently declared a Semi-Annual dividend, which was paid on Tuesday, July 31st. Shareholders of record on Tuesday, July 17th were given a dividend of $0.085 per share. The ex-dividend date was Monday, July 16th. Cantel Medical’s dividend payout ratio is currently 8.17%.

Separately, ValuEngine upgraded Cantel Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd.

About Cantel Medical

Cantel Medical Corp. provides infection prevention products and services for the healthcare market worldwide. The company operates through four segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Further Reading: Price to Earnings Ratio (PE) Basics

Insider Buying and Selling by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply